Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Arthritis, Rheumatoid 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Graft vs Host Disease 6Leukemia 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Lymphoma, Follicular 4Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 3Lymphoma 3Psoriasis 2Neoplasms 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Burkitt Lymphoma 2Urinary Bladder Neoplasms 1Stomatitis 1Recurrence 1Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Osteosarcoma 1Neutropenia 1Mycosis Fungoides 1Multiple Myeloma 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lymphoproliferative Disorders 1

Interventions

tofacitinib 7Etanercept 4deucravacitinib 2Methotrexate 2Adalimumab 2sotrastaurin 1sodium luminolate 1secukinumab 1ixekizumab 1calcipotriene 1baricitinib 1apremilast 1abrocitinib 1Anti-Infective Agents, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Psoriasis × Methotrexate × Clear all
NCT03424629 2018-04-20

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

Tianjin Ever Union Biotechnology Co., Ltd.

Phase 1 Unknown
57 enrolled
Lymphoid

Lymphoma, Follicular, Psoriasis

NCT02196701 2018-03-19

CLEAR

AbbVie

Phase 3 Completed
46 enrolled 27 charts

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡